跳至主要内容

Quantification of peptides in human synovial fluid using liquid chromatography–tandem mass spectrometry

Author:Araceli Garcia-Ac, Sung VoDuy, Sébastien Sauvé, Florina Moldovan, V. Gaëlle Roullin, Xavier Banquy   《Talanta》


ABSTRACTS
A method to explore the stability of two anti-inflammatory peptides in human synovial fluid (HSF) has been developed and validated using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The two peptides are BQ123 Cyclo(-D-Trp-D-Asp-L-Pro-D-Val-L-Leu, Mw = 610.7) and R-954 (AcOrn[Oic2, (αMe)Phe5, DβNal7, Ile8]desArg9-bradykinin, Mw =?1194.4). Human synovial fluid samples were analyzed after a protein precipitation step with acetonitrile and dilution with mobile phase. DMSO was used as anti-adsorptive agent. We used an octyl silane column with formic acid (0.1%, v/v) in water as the aqueous mobile phase and acetonitrile isopropanol-formic acid (20:80, 0.1?v/v) as the organic mobile phase and 0.7?mL/min flow rate. The peptides CY-771 and pepstatin A were used as internal standards. Selective detection was performed by tandem mass spectrometry with a heated electrospray source (HESI), operated in positive ionization mode and in selected reaction monitoring acquisition (SRM). The method limit of quantification (injection volume = 10?μL) was 0.17?ng and 1.2?ng, corresponding to 28 and 102?nmol?L?1 for BQ123 and R-954 respectively in human synovial fluid. Calibration curves obtained using matrix-matched calibration standards and internal standard were linear from 20 to 1000?nmol?L?1. Precision values (%R.S.D.) were ≤?14% in the entire linear range. Accuracy measured at a low and a high concentration level ranged from 93.1% to 102%. The recoveries (at 800?nmol?L?1) were 96.4% for BQ123 and 102.0% for R-954. The method was successfully applied to follow the degradation kinetics of both peptides in human synovial fluid from arthritic patients during 72?h.

Graphical abstract


KEY WORDS
Quantitative bioanalysis; Tandem mass spectrometry; Peptide quantification; B1 receptor; Endothelin receptor antagonist; Synovial fluid; Knee osteoarthritis; Distribution coefficient
SCREENSHOT

RELATED PRODUCTS
 BQ123, Cyclo(-D-Trp-D-Asp-L-Pro-D-Val-L-Leu), 95.51% pure was purchased from China peptides Co.
CHAINING
https://www.sciencedirect.com/science/article/pii/S003991401830345X

评论

此博客中的热门博文

CAS:198483-36-2|Cholecystokinin Octapeptide (1-6) (desulfated)|DYMGWM

Contact: Liven Qian(钱叶华)-Custom Peptide Mobile: 13761298676(微信) Email:cps037@chinapeptides.net QQ:2880526724 ChinaPeptides Co., Ltd./强耀生物科技有限公司 Name Cholecystokinin Octapeptide (1-6) (desulfated) Code [198483-36-2] The alias Cholecystokinin Octapeptide (1-6) (desulfated) Sequence (single letter abbreviation) DYMGWM Sequence (three-letter abbreviation) Asp-Tyr-Met-Gly-Trp-Met A basic description solubility The molecular weight 801.94 Chemical formula C36H47N7O10S2 The purity 80%,90%,95%,98%,99% Weight 1mg,5mg,10mg,50mg,100mg,1g Storage conditions Store at -20°C. Keep tightly closed. Store in a cool dry place.

Mitochondria Targeted Peptide Attenuates Mitochondrial Dysfunction, Controls Inflammation and Protects Against Spinal Cord Injury-Induced Lung Injury

文献作者:Zhu L.-L. · Li M.-Q. · He F. · Zhou S.-B. · Jiang W.     《Cellular Physiology and Biochemistry》 ABSTRACTS Background/Aims:   Spinal cord injury (SCI) is a common and devastating disease, which results in systemic inflammatory response syndrome and secondary lung injury. Mitochondrial dysfunction and inflammation are closely related to lung injury in diverse disease models. No studies have demonstrated the effects of mitochondrial targeted peptide SS-31 in a mouse model of SCI-induced lung injury.  Methods:   Immediately after injury, mice in the treatment groups received a daily, single-dose intraperitoneal injection of SS-31 and for the next 2 days. The sham and SCI groups also received a daily single dose of vehicle (DMSO and 0.9% NaCl, 1: 3). The lung tissue of mice was examined after SCI, and tissue damage, apoptosis, inflammation, and mitochondrial dysfunction were recorded.  Results:   SS-31 treatment attenuated lung edema ...

CAS:83651-90-5|α-CGRP (mouse, rat)|SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2

Contact: Liven Qian(钱叶华)-Custom Peptide Mobile: 13761298676(微信) Email:cps037@chinapeptides.net QQ:2880526724 ChinaPeptides Co., Ltd./强耀生物科技有限公司 Name α-CGRP (mouse, rat) Code [83651-90-5] The alias α-CGRP (mouse, rat) Sequence (single letter abbreviation) SCNTATCVTHRLAGLLSRSGGVVK DNFV PTNVGSEAF-NH2 Sequence (three-letter abbreviation) Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 A basic description solubility The molecular weight Chemical formula The purity 80%,90%,95%,98%,99% Weight 1mg,5mg,10mg,50mg,100mg,1g Storage conditions Store at -20°C. Keep tightly closed. Store in a cool dry place. Number of Residues: 37 1-Letter Code: SCNTATCVTHRLAGLLSRSGGVVK DNFVPTNVGSEAF-NH2 3-Letter Code: Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 Molecular ...